Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-interventional Study of Disease Progression and Treatment of Patients With Polycythemia Vera in United States Academic or Community Clinical Practices

NCT02252159 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT02252159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02252159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-interventional Study of Disease Progression and Treatment of Patients With Polycythemia Vera in United States Academic or Community Clinical Practices
Lead sponsor
Incyte Corporation
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
August 3, 2019
Enrollment
2,544 (actual)
Sites
266

Conditions

As the registry lists them; a condition with its own page is linked.

mpn (myeloproliferative neoplasms)